These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 16289798)

  • 1. Activation of CB1 and CB2 receptors attenuates the induction and maintenance of inflammatory pain in the rat.
    Elmes SJR; Winyard LA; Medhurst SJ; Clayton NM; Wilson AW; Kendall DA; Chapman V
    Pain; 2005 Dec; 118(3):327-335. PubMed ID: 16289798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of peripheral cannabinoid CB1 and CB2 receptors suppresses the maintenance of inflammatory nociception: a comparative analysis.
    Gutierrez T; Farthing JN; Zvonok AM; Makriyannis A; Hohmann AG
    Br J Pharmacol; 2007 Jan; 150(2):153-63. PubMed ID: 17160008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cannabinoid CB2 receptor activation inhibits mechanically evoked responses of wide dynamic range dorsal horn neurons in naïve rats and in rat models of inflammatory and neuropathic pain.
    Elmes SJ; Jhaveri MD; Smart D; Kendall DA; Chapman V
    Eur J Neurosci; 2004 Nov; 20(9):2311-20. PubMed ID: 15525273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of inflammatory hyperalgesia by activation of peripheral CB2 cannabinoid receptors.
    Quartilho A; Mata HP; Ibrahim MM; Vanderah TW; Porreca F; Makriyannis A; Malan TP
    Anesthesiology; 2003 Oct; 99(4):955-60. PubMed ID: 14508331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of peripheral cannabinoid receptors attenuates cutaneous hyperalgesia produced by a heat injury.
    Johanek LM; Simone DA
    Pain; 2004 Jun; 109(3):432-442. PubMed ID: 15157704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-nociceptive interactions between opioids and a cannabinoid receptor 2 agonist in inflammatory pain.
    Yuill MB; Hale DE; Guindon J; Morgan DJ
    Mol Pain; 2017; 13():1744806917728227. PubMed ID: 28879802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CB1 and CB2 receptor agonists promote analgesia through synergy in a murine model of tumor pain.
    Khasabova IA; Gielissen J; Chandiramani A; Harding-Rose C; Odeh DA; Simone DA; Seybold VS
    Behav Pharmacol; 2011 Sep; 22(5-6):607-16. PubMed ID: 21610490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-Dose Cannabinoid Type 2 Receptor Agonist Attenuates Tolerance to Repeated Morphine Administration via Regulating μ-Opioid Receptor Expression in Walker 256 Tumor-Bearing Rats.
    Zhang M; Wang K; Ma M; Tian S; Wei N; Wang G
    Anesth Analg; 2016 Apr; 122(4):1031-7. PubMed ID: 26720619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitory effects of CB1 and CB2 receptor agonists on responses of DRG neurons and dorsal horn neurons in neuropathic rats.
    Sagar DR; Kelly S; Millns PJ; O'Shaughnessey CT; Kendall DA; Chapman V
    Eur J Neurosci; 2005 Jul; 22(2):371-9. PubMed ID: 16045490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CB1 and CB2 cannabinoid receptors are implicated in inflammatory pain.
    Clayton N; Marshall FH; Bountra C; O'Shaughnessy CT
    Pain; 2002 Apr; 96(3):253-260. PubMed ID: 11972997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CB1 and CB2 cannabinoid receptor agonists induce peripheral antinociception by activation of the endogenous noradrenergic system.
    Romero TR; Resende LC; Guzzo LS; Duarte ID
    Anesth Analg; 2013 Feb; 116(2):463-72. PubMed ID: 23302980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective activation of cannabinoid CB(2) receptors suppresses spinal fos protein expression and pain behavior in a rat model of inflammation.
    Nackley AG; Makriyannis A; Hohmann AG
    Neuroscience; 2003; 119(3):747-57. PubMed ID: 12809695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of cannabidiolic acid and ∆
    Rock EM; Limebeer CL; Parker LA
    Psychopharmacology (Berl); 2018 Nov; 235(11):3259-3271. PubMed ID: 30225659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repeated morphine treatment-mediated hyperalgesia, allodynia and spinal glial activation are blocked by co-administration of a selective cannabinoid receptor type-2 agonist.
    Tumati S; Largent-Milnes TM; Keresztes A; Ren J; Roeske WR; Vanderah TW; Varga EV
    J Neuroimmunol; 2012 Mar; 244(1-2):23-31. PubMed ID: 22285397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of cannabinoid CB2 receptors suppresses C-fiber responses and windup in spinal wide dynamic range neurons in the absence and presence of inflammation.
    Nackley AG; Zvonok AM; Makriyannis A; Hohmann AG
    J Neurophysiol; 2004 Dec; 92(6):3562-74. PubMed ID: 15317842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of cannabinoid receptor 1 and the peroxisome proliferator-activated receptor α in mediating anti-nociceptive effects of synthetic cannabinoids and a cannabinoid-like compound.
    Alsalem M; Haddad M; Aldossary SA; Kalbouneh H; Altarifi A; Jaffal SM; Abbas MA; Aldaoud N; El-Salem K
    Inflammopharmacology; 2019 Dec; 27(6):1131-1142. PubMed ID: 30945071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiinflammatory action of endocannabinoid palmitoylethanolamide and the synthetic cannabinoid nabilone in a model of acute inflammation in the rat.
    Conti S; Costa B; Colleoni M; Parolaro D; Giagnoni G
    Br J Pharmacol; 2002 Jan; 135(1):181-7. PubMed ID: 11786493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intraplantar injection of anandamide inhibits mechanically-evoked responses of spinal neurones via activation of CB2 receptors in anaesthetised rats.
    Sokal DM; Elmes SJ; Kendall DA; Chapman V
    Neuropharmacology; 2003 Sep; 45(3):404-11. PubMed ID: 12871657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral administration of Ginkgo biloba extract, EGb-761 inhibits thermal hyperalgesia in rodent models of inflammatory and post-surgical pain.
    Biddlestone L; Corbett AD; Dolan S
    Br J Pharmacol; 2007 May; 151(2):285-91. PubMed ID: 17375081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of cannabinoid CB2 receptors reduces hyperalgesia in an experimental autoimmune encephalomyelitis mouse model of multiple sclerosis.
    Fu W; Taylor BK
    Neurosci Lett; 2015 May; 595():1-6. PubMed ID: 25849525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.